Olema Pharmaceuticals, Inc. (OLMA)
27.14
-2.05
(-7.02%)
USD |
NASDAQ |
Jan 16, 16:00
27.10
-0.04
(-0.15%)
After-Hours: 20:00
Olema Pharmaceuticals Free Cash Flow: -134.67M for Sept. 30, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Pfizer Inc. | 10.38B |
| Cidara Therapeutics, Inc. | -132.94M |
| Cogent Biosciences, Inc. | -246.73M |
| Replimune Group, Inc. | -269.69M |
| Genprex, Inc. | -15.08M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -34.53M |
| Cash from Investing (Quarterly) | 17.27M |
| Cash from Financing (Quarterly) | 0.041M |
| Free Cash Flow Per Share (Quarterly) | -0.4027 |
| Free Cash Flow to Equity (Quarterly) | -34.25M |
| Free Cash Flow to Firm (Quarterly) | -34.53M |
| Free Cash Flow Yield | -6.00% |